| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 23.542 | 23.071 | 38.506 | 47.836 | 58.225 | 58.081 | 73.918 | 100.449 | 110.484 | 115.206 |
| Total Income - EUR | 23.672 | 23.071 | 40.450 | 48.249 | 58.225 | 58.082 | 73.918 | 100.452 | 110.496 | 119.765 |
| Total Expenses - EUR | 20.202 | 21.270 | 34.927 | 43.599 | 47.057 | 55.572 | 69.101 | 89.305 | 99.744 | 117.376 |
| Gross Profit/Loss - EUR | 3.470 | 1.801 | 5.523 | 4.651 | 11.168 | 2.510 | 4.817 | 11.147 | 10.752 | 2.389 |
| Net Profit/Loss - EUR | 2.760 | 1.532 | 5.138 | 4.172 | 10.586 | 1.974 | 4.293 | 10.196 | 9.702 | 1.355 |
| Employees | 1 | 2 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 |
Check the financial reports for the company - Daly Medivet S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.674 | 2.229 | 1.781 | 19.299 | 14.637 | 10.152 | 12.888 | 11.854 | 8.448 | 48.540 |
| Current Assets | 5.048 | 7.370 | 13.721 | 12.475 | 32.966 | 28.834 | 35.237 | 41.717 | 64.449 | 67.598 |
| Inventories | 1.415 | 2.440 | 6.915 | 9.767 | 11.261 | 18.306 | 20.040 | 19.682 | 25.836 | 36.054 |
| Receivables | 0 | 0 | 996 | 1.318 | 6.915 | 6.784 | 7.279 | 9.798 | 14.613 | 13.508 |
| Cash | 3.633 | 4.931 | 5.811 | 1.390 | 14.790 | 3.743 | 7.918 | 12.237 | 24.000 | 18.037 |
| Shareholders Funds | 7.083 | 8.543 | 13.536 | 17.460 | 27.707 | 29.156 | 32.802 | 43.100 | 52.671 | 53.732 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 639 | 1.057 | 1.965 | 14.314 | 19.895 | 9.830 | 15.323 | 10.471 | 20.226 | 62.406 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Daly Medivet S.r.l.